Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 70LOXO ONCOL ELI LILLY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 213246

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10137124

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10137124

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10137124

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10137124

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SELPERCATINIB

US Patent Number : 10137124

Drug Substance Claim :

Drug Product Claim :

Application Number : 213246

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank